Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Wilex claims new urokinase inhibitors and their use as antitumor agents

Jan. 23, 2004

Triapine enters NCI-sponsored clinical trials

Jan. 22, 2004

ABX-EGF enters pivotal trial for colorectal cancer

Jan. 22, 2004

FDA approval for cytarabine aNDA

Jan. 22, 2004

MPC-6827 causes pancreatic tumor regression in preclinical studies

Jan. 22, 2004

New V-ATPase inhibitors and their use as apoptosis inducers in EGFR-overexpressing cells

Jan. 22, 2004

Italian researchers describe new camptothecin analogues and their use

Jan. 22, 2004

NC-381 arrests lung tumor growth

Jan. 22, 2004

AML apoptosis induction by novel retinoid analogue

Jan. 22, 2004

Natural small molecule apoptotic inducer identified

Jan. 22, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...